Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Permanent hair dye may cause total hair loss.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Diet can influence inflammatory skin diseases.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Combining plasma rich in growth factors with hair transplant surgery may lead to faster recovery and better outcomes for hair loss treatment.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

ALKBH5 helps wounds heal faster by stabilizing PELI2 mRNA.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Both mouse and rat models are effective for testing alopecia areata treatments.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Targeting Vδ1+T-cells may help treat alopecia areata.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.